Evidence map›Paper›PMID 33855685›Full record

ArticleEJNMMI research2021

Comparison of FDG and FMISO uptakes and distributions in head and neck squamous cell cancer tumors.

Sadek A Nehmeh, Mohamed B Moussa, Nancy Lee, Pat Zanzonico, Mithat Gönen, John L Humm, Heiko Schöder

Open access · goldAbstract read
In one paragraph

Article in EJNMMI research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022
    Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Is there a role for [Clinical and translational imaging · 2024
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sadek A NehmehMedical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. nehmehs@mskcc.org.ORCID http://orcid.org/0000-0002-3129-5003
Mohamed B MoussaChemistry Department, Stony Brook University, Stony Brook, NY, USA.
Nancy LeeRadiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Pat ZanzonicoMedical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Mithat GönenMemorial Sloan-Kettering Cancer Center, New York, NY, USA.
John L HummMedical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Heiko SchöderMemorial Sloan-Kettering Cancer Center, New York, NY, USA.
Memorial Sloan Kettering Cancer Center · USStony Brook University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Hypoxia Image-Guided Radiation TherapyR01CA157770 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI LEE, NANCY Y · 2012 to 2016
$2.1M
Prognostic value of tumor hypoxia, as measured by 18F-FMISO Breath Hold PET/CTU01CA157442 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI CHAFT, JAMIE ERIN, HUMM, JOHN L · 2012 to 2014
$1.7M
NCI NIH HHS 5R01CA157770-04NCI NIH HHS P30 CA008748NCI NIH HHS U01 CA157442-3
6 · The paper itself

Abstract

purposeGlycolysis is increased by hypoxia, suggesting a possible correlation between the accumulation of 2-[18F]fluoro-2-deoxy-D-glucose (FDG) in malignant tumors and regional hypoxia defined by 1H-1-(3-[18F]fluoro-2-hydroxypropyl)-2-nitroimidazole (FMISO) PET. The aim of this study is to investigate the intra-tumoral spatial distribution and quantitative relationship between FDG and FMISO in a cohort of head and neck squamous cell cancer (HNSCC) patients.

methodsTwenty HNSCC patients with 20 primary tumors and 19 metastatic lymph nodes (LNs) underwent FDG and FMISO PET within 1 week. The metabolic target volume (MTV) was defined on the FDG PET images using a region growing algorithm. The hypoxic volume (HV) was defined by the volume of voxels in an FMISO image within the MTV that satisfy a tumor-to-blood ratio (T/B) greater than 1.2. FDG and FMISO lesions were co-registered, and a voxel-by-voxel correlation between the two datasets was performed. FDG and FMISO TVs' SUVs were also compared as well as the intra-tumoral homogeneity of the two radiotracers. Separate analysis was performed for the primary tumors and LNs.

resultsTwenty-six percent of the primary tumors and 15% of LNs showed a strong correlation (R > 0.7) between FDG and FMISO intra-tumor distributions when considering the MTV. For the HV, only 19% of primary tumors and 12% of LN were strongly correlated. A weak and moderate correlation existed between the two markers SUV

conclusionsA moderate correlation between FDG and hypoxia radiotracer distribution, as measured by FMISO, seems to exist for primary tumors. However, discordant results were found in the case of LNs. Hypoxia appears to be the dominant driver of high FDG uptake in selected tumors only, and therefore FDG PET images cannot be used as a universal surrogate to identify or predict intra-tumor hypoxia.

Indexed as

FDGFMISOGlucose metabolismHypoxia

Identifiers

PMID33855685
PMCPMC8046891
OpenAlexW3156755984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.